B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED NIDDM PATIENTS, Diabetologia, 38, 1995, pp. 195-195
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal